Medplus Health Services share price
NSE: MEDPLUSBSE: 543427RetailingSmall Cap
Medplus Health Services Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2021 · Issue price ₹796
Last close ₹579.90down ₹18.15 (3.03%)BSE ₹579.80
Share price at the NSE close on 30 Oct 2026. Previous close ₹598.05.
30 Oct: open ₹590.00, high ₹595.00, low ₹565.60
52-week range of traded prices to 30 Oct 2026
₹565.60Low, 30 Oct 2026₹1,022.20High, 21 May 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6,967 Cr555th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 33.01
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.37
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 15.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 4,07,353
About Medplus Health Services
MedPlus Health Services Limited is a retail pharmacy chain in India that sells medicines, wellness products and fast-moving consumer goods (FMCG, everyday household items) to consumers through its stores and an online platform.12 It also runs diagnostic centres in Hyderabad, Telangana, offering pathology and radiology services.34
It was established in 2006 by Gangadi Madhukar Reddy, who is its Chairman, Managing Director and CEO.56 It operates in 13 states and 1 union territory, and describes itself as India’s second-largest pharmacy chain by revenue.78 Besides retail pharmacy and diagnostics, it reports an others segment, which covers insurance broking.4 Its private label (own-brand) products include MedPlus-branded pharmaceuticals for acute and chronic ailments, and non-pharmaceutical items such as packaged food, baby products, cleaning products, cosmetics and toiletries.910 Its material subsidiary (a subsidiary large enough to count as significant to the group) is Optival Health Solutions Private Limited.11 Its promoters are Agilemed Investments Private Limited and Gangadi Madhukar Reddy.12
Medplus Health Services key points
Results
- In the quarter to Sep 2026, consolidated revenue was ₹20,371 million, up 21.3% year on year, and gross margin (sales minus cost of goods sold, as a share of sales) was 25.1%, 110 basis points (hundredths of a percentage point) lower than a year earlier.1314
- In the quarter to Sep 2026, consolidated EBITDA (earnings before interest, tax, depreciation and amortisation) was ₹1,906.0 million; company operating EBITDA, a company measure struck after rental expenses and adjusted for one-off expenses like ESOP (employee share option) costs, was ₹981.1 million.151614
- In the year to Mar 2026, consolidated revenue was ₹68,924.66 million, up 12.33% from the year before, and consolidated profit after tax was ₹2,196.06 million.1718
- Consolidated gross margin was 26.23% in the year to Mar 2026, against 24.37% a year earlier, which the company calls a new high.19
Business segments
Private label
- The private label range (products sold under the company’s own brand) has 1750+ SKUs (distinct products): over 900 pharma products and over 850 non-pharma products.22
Branches and reach
- The company had 5,642 stores at 30 Sep 2026, after opening 219 stores and closing 53 in the quarter to Sep 2026.2324
- Of the 146 net new stores in the quarter to Jun 2026, 131 were franchisee stores (run by independent owners under the company’s brand).25
- Stores older than 12 months had revenue growth of 13.2%, an 11.7% store level EBITDA margin and a 72.0% annualised store level operating ROCE (store operating profit after depreciation as a share of store inventory, capex and security deposits) in the quarter to Sep 2026.261627
Expansion and capital spending
Recent events
- On 3 Oct 2026, CareEdge Ratings reaffirmed the credit ratings (an agency's grade of ability to repay debt) of subsidiary Optival Health Solutions Private Limited: CARE A; Stable on ₹236.00 crore of long-term bank facilities and CARE A1 on ₹14.00 crore of short-term ones.30
- On 31 Dec 2025, promoter Agilemed Investments Private Limited told the exchanges it had unpledged (released from security) 41,71,970 equity shares.31
- On 19 Dec 2025, promoter Agilemed Investments Private Limited told the exchanges it had pledged (offered as security for a loan) 48,51,066 equity shares; the company had said the pledge was linked to refinancing Agilemed's debt through non-convertible debentures (a type of bond).3233
- On 12 Dec 2025, promoters Agilemed Investments Private Limited and Gangadi Madhukar Reddy signed a debenture trust deed (an agreement naming a trustee for bondholders) with Catalyst Trusteeship Limited.34
Litigation and regulatory matters
- Subsidiary Optival Health Solutions Private Limited received an income tax demand of ₹43.45 crore, and the High Court of Telangana ruled in its favour by an order of 21 Nov 2025.3536
- As of its annual report of 23 Jul 2026, the Income Tax Department's review petition (a request that the same court re-examine its order), filed on 23 Dec 2025, was pending before the High Court; the company's documents give no outcome.3637
Last updated
All 37 sources, each with its page
- 1. Annual report, 23 Jul 2026, page 49
- 2. Annual report, 23 Jul 2026, page 3
- 3. Annual report, 23 Jul 2026, page 23
- 4. Annual report, 23 Jul 2026, page 23
- 5. Annual report, 23 Jul 2026, page 23
- 6. Annual report, 23 Jul 2026, page 6
- 7. Investor presentation, 27 Oct 2026, page 10
- 8. Annual report, 23 Jul 2026, page 23
- 9. Annual report, 23 Jul 2026, page 7
- 10. Annual report, 23 Jul 2026, page 5
- 11. Exchange filing, 3 Oct 2026, page 1
- 12. Exchange filing, 18 Dec 2025, page 1
- 13. Investor presentation, 27 Oct 2026, page 5
- 14. Investor presentation, 27 Oct 2026, page 6
- 15. Investor presentation, 27 Oct 2026, page 18
- 16. Investor presentation, 27 Oct 2026, page 26
- 17. Annual report, 23 Jul 2026, page 25
- 18. Annual report, 23 Jul 2026, page 23
- 19. Annual report, 23 Jul 2026, page 23
- 20. Investor presentation, 27 Oct 2026, page 18
- 21. Annual report, 23 Jul 2026, page 25
- 22. Investor presentation, 27 Oct 2026, page 9
- 23. Investor presentation, 27 Oct 2026, page 5
- 24. Investor presentation, 27 Oct 2026, page 12
- 25. Earnings call, 22 Jul 2026, page 13
- 26. Investor presentation, 27 Oct 2026, page 5
- 27. Investor presentation, 27 Oct 2026, page 14
- 28. Earnings call, 22 Jul 2026, page 3
- 29. Earnings call, 22 Jul 2026, page 4
- 30. Exchange filing, 3 Oct 2026, page 1
- 31. Exchange filing, 31 Dec 2025, page 2
- 32. Exchange filing, 19 Dec 2025, page 2
- 33. Exchange filing, 18 Dec 2025, page 2
- 34. Exchange filing, 18 Dec 2025, page 1
- 35. Annual report, 23 Jul 2026, page 123
- 36. Exchange filing, 23 Jan 2026, page 1
- 37. Annual report, 23 Jul 2026, page 123
Results
Consolidated; ₹ crore.Medplus Health Services quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +20.6%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +8.2%
Quarter to Sep 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹2,037 Crup 8.38%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹56 Crup 69.05%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 2.8%
Revenue by quarter
Peak revenue ₹2,037 Cr, quarter to Sep 2026; lowest ₹1,510 Cr, quarter to Mar 2025
Net profit by quarter, a loss in red
| ₹ crore | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,561 | 1,510 | 1,543 | 1,679 | 1,806 | 1,864 | 1,880 | 2,037 |
| Net profit | 46 | 51 | 42 | 56 | 58 | 64 | 33 | 56 |
| Net margin | 2.9% | 3.4% | 2.7% | 3.3% | 3.2% | 3.4% | 1.8% | 2.8% |
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹6,892 Crup 12.33%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹220 Crup 46.18%
- Net margin
- 3.2%
Revenue by year
Peak revenue ₹6,892 Cr, year to Mar 2026; lowest ₹3,779 Cr, year to Mar 2022
Net profit by year, a loss in red
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 3,779 | 4,558 | 5,625 | 6,136 | 6,892 |
| Net profit | 95 | 50 | 66 | 150 | 220 |
| Net margin | 2.5% | 1.1% | 1.2% | 2.4% | 3.2% |
Consolidated. Years to March. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
Share of revenue, year to Mar 2026, consolidated.Segment revenue and profit
- RetailRetail, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹6,760 Crup 12.17%98.1%
- Diagnostic servicesDiagnostic services, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹131 Crup 21.16%1.9%
- OthersOthers, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹1 Cr0.0%
The pill is the change in revenue on the year before; the share is of all the businesses together.
Valuation
Today, against the company's own history. Dividend yield is not shown: no dividend in the years on record.Medplus Health Services PE ratio and valuation
Price to earnings
At or below today's level on 0.1% of 976 trading days since Nov 2022.
LowestHighest
Its median101.37Industry median21.68
Price to book
At or below today's level on 0.1% of 1,087 trading days since Jun 2022.
LowestHighest
Its median5.48Industry median2.43
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +10.5% | +45.8% | −24.2% | 0.0% |
| 3 years | +8.9% | +63.8% | −33.5% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add.
Mutual fund holdings
33 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 9 of the 13 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future. 1 more fund filed its first portfolio on record, holding it.All 33 funds holding Medplus Health Services
- AddedAdded. Funds that held more shares than at the end of the month before.
- 6
- CutCut. Funds that held fewer shares than at the end of the month before.
- 7
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 19
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end. Sold out in the glossary
- 2
| Fund | |||
|---|---|---|---|
 ICICI Prudential Healthcare FundICICI Prudential Mutual Fund | 45,14,490 | 4.31% | ₹295.7 Cr |
 SBI ELSS Tax Saver FundSBI Mutual Fund | 40,67,968 | 0.89% | ₹266.4 Cr |
 Kotak-Small Cap FundKotak Mahindra Mutual Fund | 35,78,425 | 1.22% | ₹234.4 Cr |
 Nippon India Pharma FundNippon India Mutual Fund | 35,45,229 | 2.53% | ₹232.2 Cr |
| Nippon India Multi Cap FundNippon India Mutual Fund | 25,27,912 | 0.31% | ₹165.6 Cr |
 Franklin India Small Cap FundFranklin Templeton Mutual Fund | 23,65,629 | 1.09% | ₹154.9 Cr |
| Nippon India Focused FundNippon India Mutual Fund | 20,98,553 | 1.70% | ₹137.4 Cr |
| ICICI Prudential Innovation FundICICI Prudential Mutual Fund | 19,09,073 | 1.66% | ₹125.0 Cr |
| Franklin India Flexi Cap FundFranklin Templeton Mutual Fund | 17,11,985 | 0.62% | ₹112.1 Cr |
| ICICI Prudential Aggressive Hybrid FundICICI Prudential Mutual Fund | 14,57,063 | 0.19% | ₹95.4 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Promoter and insider buying and selling
Trades made since 30 Oct 2025.Medplus Health Services insider trading
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade · 1 pledge created · 1 pledge released · 8 pledge filings of unclear kind
- Others: no market trade · 7 pledge filings of unclear kind · 1 off-market move
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Medplus Health Services competitors and peers
Retailing, 83 listed companies, priced on 30 Oct 2026. The table lists the 8 companies closest to Medplus Health Services in market cap.Consumer services companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Indiamart IntermeshINDIAMART | 8,944 | 17.84 | 3.86 | +12.0% | −6.7% | 22.5% | 23.5% | 4.03% |
 Aditya Birla Lifestyle BrandsABLBL | 8,606 | 48.90 | 6.09 | – | – | 12.5% | 25.0% | 0.71% |
 Brainbees SolutionsFIRSTCRY | 8,237 | – | 1.71 | +11.7% | – | −2.6% | −1.9% | 0.00% |
 Aditya VisionAVL | 7,090 | 49.15 | 9.23 | +27.6% | +33.5% | 20.5% | 21.4% | 0.23% |
 Entero Healthcare SolutionsENTERO | 6,856 | 54.67 | 4.06 | +31.9% | +22.3% | 7.3% | 11.5% | 0.00% |
 V-Mart RetailVMART | 5,885 | 42.76 | 6.19 | +19.1% | +104.7% | 15.6% | 22.3% | 0.14% |
 Electronics Mart IndiaEMIL | 5,838 | 28.32 | 3.59 | +16.8% | +88.8% | 13.1% | 16.2% | 0.00% |
 Just DialJUSTDIAL | 5,481 | 11.14 | 1.02 | +9.0% | −13.4% | 9.6% | 6.0% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Medplus Health Services announcements
Oct 2026
17 Oct · Analysts
Medplus Health Services share price by year
Each calendar year to 2025.Medplus Health Services share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 807.30 | −2.8% | 977.20 | 694.50 |
| 2024 | 830.85 | +10.7% | 865.35 | 602.95 |
| 2023 | 750.75 | +22.4% | 959.05 | 603.95 |
| 2022 | 613.60 | −40.8% | 1,290.00 | 576.30 |
| 2021 | 1,037.35 | – | 1,121.15 | 1,002.65 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2021 is from its first session, 23 Dec 2021.
Recent sessions
The 9 trading days to 29 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 29 Oct 2026 | 609.40 | 609.40 | 595.80 | 598.05 | 601.09 | 1,42,234 | 69.4% |
| 28 Oct 2026 | 648.95 | 648.95 | 602.30 | 609.40 | 612.09 | 1,82,017 | 43.8% |
| 27 Oct 2026 | 612.50 | 628.00 | 605.15 | 621.45 | 614.93 | 66,901 | 49.8% |
| 26 Oct 2026 | 591.35 | 615.00 | 582.60 | 608.15 | 601.03 | 60,823 | 54.9% |
| 23 Oct 2026 | 594.00 | 599.80 | 576.30 | 595.15 | 588.44 | 1,18,627 | 49.9% |
| 22 Oct 2026 | 590.80 | 598.85 | 588.10 | 594.70 | 593.52 | 62,001 | 51.3% |
| 21 Oct 2026 | 599.35 | 603.75 | 591.40 | 598.80 | 596.80 | 31,997 | 44.6% |
| 19 Oct 2026 | 615.00 | 615.10 | 592.70 | 599.35 | 599.06 | 99,062 | 56.1% |
| 16 Oct 2026 | 614.95 | 615.00 | 608.80 | 611.95 | 612.22 | 32,245 | 56.0% |
Prices in ₹ per share as traded, not adjusted.
Company details
- Chairperson and managing director and CEO
- Gangadi Madhukar Reddy
- At the end of the quarter to Sep 2026
- NSE symbol
- MEDPLUS
- BSE code
- 543427
- ISIN
- INE804L01022
- Industry
- Retailing
- Website
- www.medplusindia.com
- CIN
- L85110TG2006PLC051845
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2006
- Registered office
- H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad 500037, Telangana
- Share registrar
- KFin Technologies Ltd
- Keeps the register of shareholders and handles transfers and dividend payments